Amarin Corp Plcuk (AMRN) Gross Margin (2013 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Gross Margin of 39.37% for Q1 2026, down 2044.0% YoY from 2.03% in Q1 2025, and down 16.36% sequentially from 47.07% in Q4 2025.

Amarin Corp Plcuk (AMRN) Gross Margin (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Gross Margin across 14 years of filings, most recently posting 39.37% for Q1 2026.

  • In Q1 2026, Gross Margin fell 2044.0% year-over-year to 39.37%; the TTM figure through Mar 2026 stood at 52.37% (up 1752.0% YoY), while the FY2025 annual figure was 56.57%, up 2098.0% from the prior year.
  • Gross Margin fell to 39.37% in Q1 2026, from 47.07% in the prior quarter.
  • Over the last five years, Gross Margin for AMRN reached as high as 76.5% in Q1 2022 and fell as low as 15.35% in Q4 2024.
  • The 5-year median for Gross Margin is 55.75% (2023), against an average of 51.81%.
  • Annual changes were most pronounced in 2024 — Gross Margin tumbled 7575 bps — and 2025, when it soared 6243 bps.
  • A 5-year view of Gross Margin shows it stood at 70.48% in 2022, then slipped by 14 bps to 60.4% in 2023, then slumped by 125 bps to 15.35% in 2024, then jumped by 407 bps to 47.07% in 2025, then dropped by 16 bps to 39.37% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods registered 39.37%, 47.07%, and 44.71% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 81.93%
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 66.31%
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 71.88%
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 87.65%
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 74.24%
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 68.16%
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 79.24%
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -51.69%
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 39.37%

Historic Data

Download Data
DateValue
Mar 31, 2026 39.37%
Dec 31, 2025 47.07%
Sep 30, 2025 44.71%
Jun 30, 2025 69.23%
Mar 31, 2025 59.81%
Dec 31, 2024 -15.35%
Sep 30, 2024 38.48%
Jun 30, 2024 63.37%
Mar 31, 2024 56.45%
Dec 31, 2023 60.40%
Sep 30, 2023 45.15%
Jun 30, 2023 53.22%
Mar 31, 2023 55.75%
Dec 31, 2022 70.48%
Sep 30, 2022 69.94%
Jun 30, 2022 46.20%
Mar 31, 2022 76.50%
Dec 31, 2021 78.80%
Sep 30, 2021 78.73%
Jun 30, 2021 79.19%